Skip to main content
ENDO 2026 Main banner

Cherie Stabler, Ph.D. (she/her/hers)

Professor & Departmental Chair
University of Florida
Gainesville, FL, United States

Dr. Cherie Stabler is the J. Crayton Pruitt Family & UF Foundation Preeminence Term Professor and Departmental Chair in the Department of Biomedical Engineering, College of Engineering at the University of Florida. She is also an Affiliate Member of the UF Diabetes Institute. She received her Ph.D. in Biomedical Engineering from The Georgia Institute of Technology & Emory University and conducted her postdoctoral work in the Department of Surgery at Emory University. Prior to being recruited to UF in 2015 as part of the UF Preeminence Initiative, she was an Associate Professor of Biomedical Engineering at the University of Miami, where she also served as the Director of the Tissue Engineering Laboratory at the Diabetes Research Institute (2006-2014). Dr. Stabler has established an internationally recognized research and educational program focused on generating translational biomaterial platforms for cellular implants, with a particular emphasis on cell-based therapies for Type 1 diabetes. Her novel bioactive materials are targeted at enhancing graft survival and utilizing local and translational approaches to dampen host immunological responses. Her work spans from designing new biomaterials to seeking FDA clearance for combinatory products. Her transdisciplinary research has been published in a wide range of journals and has generated numerous patents. She is an inducted fellow of the Biomedical Engineering Society (BMES), the American Institute for Medical and Biological Engineering (AIMBE), and the Academy of Science, Engineering, and Medicine of Florida (ASEMFL). She is the recipient of the NIH NIDDK Type 1 Diabetes Pathfinder DP2 Award, the 2022 UF Foundation Preeminence Term Professor, the 2022 HWCOE Doctoral Dissertation Advisor/Mentor of the Year, 2019 UF HWCOE Faculty-Scholar of the Year, and a UF Term Professor (2019-2022). She is the President of the International Tissue Engineering and Regenerative Medicine Americas Chapter (TERMIS-AM).

Disclosure information not submitted.

Presentation(s):